Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bionomics Initiates Renal Cancer Trial
The trial, which is being conducted by the Hoosier Oncology Group, is open for enrollment at the Baylor Sammons Cancer Centre, Dallas, Texas; Indiana University Melvin and Bren
The trial, which is being conducted by the Hoosier Oncology Group, is open for enrollment at the Baylor Sammons Cancer Centre, Dallas, Texas; Indiana University Melvin and Bren
The NDA submission follows a pre-NDA meeting with the FDA and the recently announced results from the phase 3 trial of Axiron. The trial demonstrated that after four
During the test period, Shionogi was able to compare HuCAL Platinum with its predecessor HuCAL Gold, and found the new library to be considerably better. As per the
The FilmArray RP includes integrated sample preparation. It requires only five minutes of hands-on time and reports results in less than an hour, claims the company. The company
The year-old partnership focuses on Jubilant delivering preclinical candidates in the therapeutic area of oncology. Endo owns the late-stage development and commercialization rights for molecules discovered in the
The compnay claims that Maris Plus stent features an exclusive cell design at the stent ends. This allows physicians to place several stents in series without stiffening the
Cenestra said that scientific data obtained from third party academic laboratories support its proprietary formulation as having novel properties compared to other omega-3 products. These studies show that
Under the settlement and cross-license agreement, Bavarian Nordic will grant a license to its MVA-BN patents, in return for Oxford BioMedica granting a license to its heterologous prime-boost
The new approval strengthens the suite of over 60 approved patents and patent applications owned and licensed by the company. It cover all aspects of the company’s technology
David Weber, vice-president of sales and marketing at Cyntellect, said: “The need to analyze cells with minimal sample manipulation, and to process cells with great precision and efficiency,